Past News
 Dec 9, 2009 - Protalix Completes NDA Submission for taliglucerase alfa for the Treatment of Gaucher's Disease
Dec 1, 2009 - Pfizer And Protalix Enter Into Agreement To Develop And Commercialize Gaucher's Disease Treatment
Dec 1, 2009 - Genzyme Begins Shipping Newly Produced Cerezyme® from Allston Plant
Nov 4, 2009 - FDA Grants Priority Review for Shire’s velaglucerase alfa for Type 1 Gaucher Disease
Oct 21, 2009 - Cerezyme® / Fabrazyme Update (See “Recovery of the Allston Plant)
Oct 20, 2009 - Genzyme announces enrollment in 2 global, multi-center, phase 3 trials of Genz-112638, potential new oral therapy for Gaucher type 1
Oct 15, 2009 - Protalix BioTherapeutics Announces Positive Top-line Results from its Phase III Clinical Trial of UPLYSO™ for the Treatment of Gaucher Disease
Sep 14, 2009 - Protalix Completes Pivotal Phase III Trial for prGCD for the Treatment of Gaucher Disease
Sep 8, 2009 - Shire Update on Velaglucerase Alpha
Sep 8, 2009 - FDA Grants Protalix Orphan Drug Designation for prGCD
Aug 25, 2009 - Protalix Receives FDA Fast Track Designation for prGCD
Aug 17, 2009 - U.S. Food and Drug Administration Approves Protalix's Treatment Protocol for prGCD
Aug 3, 2009 - Shire Reports Positive Results from First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on Interactions with FDA
Jul 16, 2009 - Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease
Jul 14, 2009 - Protalix Holds Pre-NDA Meeting with FDA for prGCD
Jul 6, 2009 - Shire has filed a treatment protocol for velaglucerase alfa for Gaucher Disease
Jul 6, 2009 - Protalix Approached by the FDA to Consider Submitting a Treatment Protocol for the Use of prGCD in Patients with Gaucher Disease Allowing Expanded Access to prGCD
Protalix BioTherapeutics Announces First Patient Enrolled in Open-Label, Switchover Trial of prGCD for the Treatment of Gaucher Disease
Protalix BioTherapeutics Receives Research Grant of over $6 Million from the Israeli Government’s Office of the Chief Scientist
Help us in the fight to save Hannah’s Life!
Amicus Therapeutics hosts Rare Disease Day event: Press Release
Expression of Hope II: Inspiration Through Art – for individuals with Lysosomal Storage Disorders (LSDs)
Group Charged With "Playing God" Over Genetic Testing
Dr. Roscoe Brady, Scientist Emeritis, 2007 National Medal of Technology and Innovation Recipient
Amicus Therapeutics Presents Positive Data from Phase 2 Clinical Trial of Plicera(TM) for Gaucher Disease
Genzyme Announces Positive Initial Observations in Trial Evaluating Novel Oral Treatment for Gaucher Disease
Genzyme Announces Publication of Study Showing Impact of CerezymeŽ on Bone Health for Patients with Type 1 Gaucher Disease
Amicus Therapeutics Receives Grant From Michael J. Fox Foundation for Parkinson's Research
Group Charged With 'Playing God' Over Genetic Testing
WORLD RARE DISEASE DAY 2009! - The rarest global event affecting 60 million people 7,000 rare diseases
National Gaucher Conference - October 14-15, 2007, Atlanta GA
12th Annual Golf Fore, Gaucher Disease Classic - September 28, 2007, Huntingdon Valley, PA
Expression of Hope Art Exhibit - November 9, 2007, through February 29, 2008, Washington D.C
Children's National Medical Center Provider's Symposium - November 28, 2007, Bethesda, MD
College students flock to screening for Jewish genetic diseases
Group hopes Gaucher becomes household name
JGDC - A Genetic Package Deal
RedOrbit.Com posts story about "Scar Art"
New Exhibit: Few people consider scars worthy of public exhibit or admiration.
"Scarred for Life" review from Washington City Paper
New art exhibit 'Scarred for Life' has emotional value
Artist Celebrates Scars' Fierce Beauty
NYU Begins Oral Therapy Trials for Gaucher Disease
Unique Art Exhibit traces the Stories behind scars
Washington Post Article: "Scarred for Life"
Gaucher Disease Deli-thon a Great Success!
Speech of HON. BARNEY FRANK of Massachusetts in the House of Representatives
Protalix Biotherapeutics completes Phase I trials
Survey Finds No Awareness of Common Genetic Disease
A Proclamation by the President of the United States of America Jewish American Heritage Month, May 2006
Infant rare-disease screening developed
Amicus Therapeutics Appoints Pharmaceutical Veteran Donald Hayden, Jr.
Proclamation 5554 -- Gaucher's Disease Awareness Week, 1986
Are Jews Smarter? (Click for link to New York Magazine article)
Physician Promotes Universal Screening for Gaucher's Disease
Researchers Uncover Genetic Clues to a Common Form of Age-Related Dementia
Gaucher Awareness Auction Coming Soon!
NGF Releases New Gaucher Radio Commercial
Gaucher Disease: Learning The Truth
Rx for an Industry: As Biotech Drug Prices Surge, U.S. Is Hunting for a Solution
National Gaucher Foundation Forms Alliance with the JGDC
Elliott Gould Narrates New DVD Promoting Awareness of Most Common Genetic Disease Facing U.S. Jews
Genetic Infusion Center Opens at Emory
PR listing of stories and airings about Gaucher disease since July of 2005 until September of 2005. |
